Research into Tesamorelin has suggested it may lead to a reduction of up to 25% in visceral fat among lipodystrophy models
GHRP-2 reliably elevates plasma ACTH and cortisol in both rodent models and the early human pharmacology studies from the 1990s
These findings are uncertain because the analyses were not adjusted for multiple comparisons, increasing the risk of type I error
What patients do report, typically transiently, includes: Injection site reaction: Brief redness or mild soreness where the needle entered, usually resolving within hours
Frontiers in endocrinology, 3, 131
Ghrelin is able to act upon the pituitary gland in this way because growth hormone is, among many other things, responsible for initiating the breakdown of fat for use as energy as well as preventing the breakdown of muscles